Methods and apparatus for treating contrast nephropathy
    6.
    发明授权
    Methods and apparatus for treating contrast nephropathy 有权
    治疗对比肾病的方法和装置

    公开(公告)号:US08551069B2

    公开(公告)日:2013-10-08

    申请号:US11368809

    申请日:2006-03-06

    CPC classification number: A61N1/05 A61N1/0551 A61N1/327 A61N1/40

    Abstract: Methods and apparatus are provided for treating contrast nephropathy, e.g., via a pulsed electric field, via a stimulation electric field, via localized drug delivery, via high frequency ultrasound, via thermal techniques, etc. Such neuromodulation may effectuate irreversible electroporation or electrofusion, necrosis and/or inducement of apoptosis, alteration of gene expression, action potential attenuation or blockade, changes in cytokine up-regulation and other conditions in target neural fibers. In some embodiments, neuromodulation is applied to neural fibers that contribute to renal function. In some embodiments, such neuromodulation is performed in a bilateral fashion. Bilateral renal neuromodulation may provide enhanced therapeutic effect in some patients as compared to renal neuromodulation performed unilaterally, i.e., as compared to renal neuromodulation performed on neural tissue innervating a single kidney.

    Abstract translation: 提供了方法和装置,例如通过脉冲电场,经由刺激电场,经由局部药物递送,经由高频超声波,通过热技术等来治疗对比肾病。这种神经调节可以实现不可逆的电穿孔或电融合,坏死 和/或诱导细胞凋亡,改变基因表达,动作电位减弱或阻断,细胞因子上调和靶神经纤维中的其他条件的变化。 在一些实施方案中,神经调节被应用于有助于肾功能的神经纤维。 在一些实施方案中,这种神经调节以双向方式进行。 与单侧执行的肾神经调节相比,双侧肾神经调节可以在一些患者中提供增强的治疗效果,即与在支配单个肾脏的神经组织上进行的肾神经调节相比。

    OCULAR INSERT APPARATUS AND METHODS
    8.
    发明申请
    OCULAR INSERT APPARATUS AND METHODS 有权
    OCULAR插入装置和方法

    公开(公告)号:US20130144128A1

    公开(公告)日:2013-06-06

    申请号:US13618052

    申请日:2012-09-14

    Abstract: A comfortable insert comprises a retention structure sized for placement under the eyelids and along at least a portion of conjunctival sac of the upper and lower lids of the eye. The retention structure resists deflection when placed in the conjunctival sac of the eye and to guide the insert along the sac when the eye moves. The retention structure can be configured in many ways to provide the resistance to deflection and may comprise a hoop strength so as to urge the retention structure outward and inhibit movement of the retention structure toward the cornea. The insert may move rotationally with deflection along the conjunctival sac, and may comprise a retention structure having a cross sectional dimension sized to fit within folds of the conjunctiva. The insert may comprise a release mechanism and therapeutic agent to release therapeutic amounts of the therapeutic agent for an extended time.

    Abstract translation: 舒适的插入物包括保持结构,其尺寸适于放置在眼睑下方并且沿着眼睛的上盖和下盖的结膜囊的至少一部分。 保留结构在放置在眼结膜囊中时抵抗偏转,并且当眼睛移动时沿着囊引导插入物。 保持结构可以以许多方式构造以提供对偏转的抵抗力,并且可以包括环箍强度,以便向外推动保持结构并阻止保持结构朝向角膜的移动。 插入件可以沿着结膜囊的偏转而旋转移动,并且可以包括保持结构,该保持结构具有尺寸适合于结膜折叠的横截面尺寸。 插入物可以包含释放机制和治疗剂以释放长期治疗剂的治疗剂量。

Patent Agency Ranking